Prices delayed by at least 15 minutes | Print
MERCK KGAA O.N. (MRK)
AKTIEN O.N.This share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. Inits electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Address
DEU
Telephone
+49 6151729591
Forecast key dates
Name | Key Date |
---|---|
Merck KGaA First Quarter Earnings Conference Call for 2025 | 2025-05-15T14:00:00 |
Merck KGaA First Quarter Earnings Results for 2025 | 2025-05-15T07:00:00 |
Merck KGaA Annual General Meeting for 2025 | 2025-04-25T10:00:00 |
Merck KGaA Annual Report for 2024 | 2025-03-19T00:00:00 |
Merck KGaA Fourth Quarter Earnings Result for 2024 | 2025-03-06T00:00:00 |
Merck KGaA Fourth Quarter Earnings Conference Call for 2024 | 2025-03-06T00:00:00 |
Merck KGaA Third Quarter Earnings Result for 2024 | 2024-11-14T00:00:00 |
Merck KGaA Third Quarter Earnings Conference Call for 2024 | 2024-11-14T00:00:00 |
Merck KGaA Second Quarter Earnings Result for 2024 | 2024-08-01T00:00:00 |
Merck KGaA Second Quarter Earnings Conference Call for 2024 | 2024-08-01T00:00:00 |
Merck KGaA First Quarter Earnings Conference Call for 2024 | 2024-05-15T14:00:00 |
Merck KGaA First Quarter Earnings Results for 2024 | 2024-05-15T07:00:00 |
Previous key dates
Name | Key Date |
---|---|
Merck KGaA First Quarter Earnings Conference Call for 2024 | 2024-05-15T14:00:00 |
Merck KGaA First Quarter Earnings Results for 2024 | 2024-05-15T07:00:00 |
Merck KGaA Annual General Meeting for 2024 | 2024-04-26T10:00:00 |
Merck KGaA Annual Report for 2023 | 2024-03-19T00:00:00 |
Merck KGaA Fourth Quarter Earnings Conference Call for 2023 | 2024-03-07T14:00:00 |
Merck KGaA Fourth Quarter Earnings Results for 2023 | 2024-03-07T07:00:00 |
Merck KGaA Third Quarter Earnings Conference Call for 2023 | 2023-11-09T14:00:00 |
Merck KGaA Third Quarter Earnings Result for 2023 | 2023-11-09T00:00:00 |
Merck KGaA Capital Market Day 2023 | 2023-10-19T10:00:00 |
Merck KGaA Second Quarter Earnings Conference Call for 2023 | 2023-08-03T14:00:00 |
Merck KGaA Second Quarter Earnings Results for 2023 | 2023-08-03T07:00:00 |
Merck KGaA First Quarter Earnings Conference Call for 2023 | 2023-05-11T14:00:00 |
Merck KGaA First Quarter Earnings Result for 2023 | 2023-05-11T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.